Novartis Home
At Novartis, we are reimagining medicine
1_azwfmd33
Life Science Companies and the Bill & Melinda Gates Foundation: Joint Communique
Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
World Heart Day 2020: From our heart to yours
For the past six decades, Novartis has been working to advance heart health around the world.
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
ESG - Committed to increasing access
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Our commitment to doing what's right
Novartis is committed to ensuring our associates are empowered to do what’s right. On September 01, 2020, we introduced a new Code of Ethics for Novartis.
Cell & Gene Therapy Explained
What if medicine for certain diseases only needed to be taken once?
Novartis at ESMO
Find the latest oncology resources on Novartis data featured at the European Society for Medical Oncology (ESMO).